Correction to: American Journal of Clinical Dermatology (2023) 24:143–151 https://doi.org/10.1007/s40257-022-00748-2


The article ‘‘Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis”, written by Sheridan M. Hoy was originally published electronically on the publisher’s internet portal (currently SpringerLink) on Dec 20, 2022 without open access. After publication in volume 24, issue 1, pages 143–151, Incyte Corporation requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Incyte Corporation. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party materials in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by-nc/4.0/.


The original article has been corrected.